Ace Ventures
VC Fund
Potsdam, Germany
Ace Ventures is a VC fund in Potsdam focused on Apps and Medical. Ace Ventures was designed to help new ideas, smart people and great companies to successfully enter the Internet business in Germany.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Ace Ventures invests in
Stages Ace Ventures invests in
Countries Ace Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series B
- $4.1M–$20M
Investment Focus
Industry
- Apps 1 (14%)
- Medical 1 (14%)
- Wedding 1 (14%)
- Internet 1 (14%)
- Aerospace 1 (14%)
Stage
- Series B 2 (29%)
- Seed 1 (14%)
- Series A 1 (14%)
- Series E 1 (14%)
- Funding Round 1 (14%)
Country
- Germany 2 (29%)
- United States 2 (29%)
- Italy 1 (14%)
- South Korea 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Daniel Klarkowski
CEO and Founder
|
CEO and Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development of new drugs to treat chronic inflammatory diseases.In recent years Kither has focused its first line of activities on the development of a small peptide(KIT2014) developed internally for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and that currently has no cure. The KIT2014 peptide was assigned the Orphan Drug designation from the European Medicines Agency. The KIT2014 compound is currently undergoing the pre-clinical phase of clinical development.Kither’s product portfolio also includes a molecule (CL27), also developed internally, that is being developed for the treatment of Chronic Obstructive Pulmonary Diseases and Allergic Asthma. The company is about to start the pre-clinical phase of development of the CL27 molecule. | $20.4M / Series B / Mar 16, 2022 | |
|
|
Joy is a wedding company that gives couples a smarter way to plan their big day. Using Joy, couples can create a beautifully-designed wedding website and mobile app, build their All-in-One Registry, manage guest lists and RSVPs, send online or printed Save the Dates, invitations and eCards, provide travel and accommodations options for guests, hostvirtual wedding events, create a shared virtual wedding album and virtual guest book, and more. Wedding guests can purchase registry gifts, book travel plans and accommodations, get directions to wedding events via a Google Maps integration, order a ride to wedding events via ride-sharing integrations, add wedding events to their calendar with a click, and more.Based in San Francisco, Joy launched in 2016 through Y Combinator. Visit withjoy.com and follow @withjoy to see why couples around the world are planning their weddings with Joy. | $20M / Series A / Sep 01, 2021 | |
|
|
iMediSync provides automatic brain wave analysis and neuromodulation solutions. | $4.1M / Series B / Mar 13, 2020 | |
|
|
Rocket Lab is a space, building rockets and spacecraft that make it easier to get to orbit and to do amazing things there. Rocket Lab provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. Headquartered in Long Beach, California, Rocket Lab designs and manufactures theElectron launch vehicles and Photon satellite platform and is developing the Neutron launch vehicle. Since its first orbital launch in January 2018, Rocket Lab’s Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 105 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab has two launch sites, including a private orbital launch site located in New Zealand, and a second launch site in Virginia, USA expected to be operational by the end of 2021. Rocket Lab’s Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. | $140M / Series E / Nov 18, 2018 | |
|
|
Rocket Lab is a space, building rockets and spacecraft that make it easier to get to orbit and to do amazing things there. Rocket Lab provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. Headquartered in Long Beach, California, Rocket Lab designs and manufactures theElectron launch vehicles and Photon satellite platform and is developing the Neutron launch vehicle. Since its first orbital launch in January 2018, Rocket Lab’s Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 105 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab has two launch sites, including a private orbital launch site located in New Zealand, and a second launch site in Virginia, USA expected to be operational by the end of 2021. Rocket Lab’s Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. | $140M / Series E / Nov 15, 2018 | |
|
|
Vigno is a pan-European weekly deals site for fine wines. Every week they showcase an exclusive selection from a carefully selected winemaker and offer it for sale. By dealing directly with the winemaker, and leveraging the power of group buying, they offer very competitive prices to their customers. Vigno was founded in March 2011 by DanielKlarkowski, Alex Lunt and Raphael Agasse in Berlin. | Seed / Mar 03, 2011 | |
|
|
Liviato is a social publishing site where people share abstracts of books. Reading and downloading of abstracts is free. Authors receive points when publishing an abstract, which can later be exchanged for rewards. | Mar 08, 2010 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ace Ventures invest in?
Ace Ventures invests primarily in Apps, Medical and Wedding startups, most often at Series B and Seed stage. Most of the 7 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ace Ventures's check size?
Ace Ventures typically joins rounds of $4.1M–$20M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ace Ventures participates in.
How do I contact Ace Ventures?
Public channels for Ace Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ace Ventures?
The team at Ace Ventures includes Daniel Klarkowski (CEO and Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!